Literature DB >> 17024592

Epidemiology and risk factors of venous thromboembolism.

Walter Ageno1, Alessandro Squizzato, David Garcia, Davide Imberti.   

Abstract

Venous thromboembolism (VTE) is a common disorder that can affect apparently healthy as well as hospitalized patients. The actual incidence and prevalence of this disease are difficult to estimate because of its often silent nature. The clinical relevance of VTE is highlighted by the important rates of recurrence and mortality. The individual risk of VTE varies as a result of a complex interaction between congenital and transient or permanent acquired risk factors. Risk factors can be either intrinsic (e.g., age, obesity, history of VTE, or thrombophilia) or disease related (e.g., surgical procedures and medical disorders such as cancer, heart failure, or acute respiratory failure). The presence or absence of specific risk factors may play an important role in decisions about the type (and duration) of thromboprophylaxis/anticoagulation to be used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024592     DOI: 10.1055/s-2006-951293

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  32 in total

1.  Elevated plasma gas6 levels are associated with venous thromboembolic disease.

Authors:  Mark D Blostein; Isabelle Rajotte; Deepa P Rao; Christina A Holcroft; Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

2.  Clinical, historical and diagnostic findings associated with right ventricular dysfunction in patients with central and non-massive pulmonary embolism.

Authors:  Domenico Rendina; Silvana De Bonis; Giovanni Gallotta; Vincenzo Piedimonte; Giuseppe Mossetti; Gianpaolo De Filippo; Francesca Farina; Giuseppe Vargas; Maria Rosaria Barbella; Alfredo Postiglione; Pasquale Strazzullo
Journal:  Intern Emerg Med       Date:  2009-11-25       Impact factor: 3.397

3.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

4.  Unsuspected pulmonary thromboemboli: a continuing clinical challenge.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2013

Review 5.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

6.  Venous thromboembolism after major orthopaedic surgery: a population-based cohort study.

Authors:  Davide Imberti; Cosetta Bianchi; Antonella Zambon; Andrea Parodi; Luca Merlino; Massimo Gallerani; Giovanni Corrao
Journal:  Intern Emerg Med       Date:  2011-03-26       Impact factor: 3.397

7.  Decompensated Heart Failure in Pregnancy.

Authors:  John Anthony; Karen Sliwa
Journal:  Card Fail Rev       Date:  2016-05

Review 8.  Current state of anticoagulants to treat deep venous thrombosis.

Authors:  Timothy Vo; Sara Vazquez; Matthew T Rondina
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

Review 9.  Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review.

Authors:  Davide Imberti; Chiara Dall'Asta; Matteo Giorgi Pierfranceschi
Journal:  Intern Emerg Med       Date:  2009-12       Impact factor: 3.397

Review 10.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.